Emergent Financial Statements From 2010 to 2024

Stocks . USA . 
Stock . Emergent Biosolutions
EBS Stock  USD 9.40  0.52  5.86%   
Emergent Biosolutions financial statements provide useful quarterly and yearly information to potential Emergent Biosolutions investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Emergent Biosolutions financial statements helps investors assess Emergent Biosolutions' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Emergent Biosolutions' valuation are summarized below:
Gross Profit
290.1 M
Profit Margin
(0.19)
Market Capitalization
540.2 M
Enterprise Value Revenue
0.9083
Revenue
1.1 B
There are over one hundred nineteen available fundamental signals for Emergent Biosolutions, which can be analyzed over time and compared to other ratios. All traders should verify Emergent Biosolutions' prevailing fundamentals against the performance from 2010 to 2024 and make sure the trends continue to evolve in the right direction. Market Cap is likely to gain to about 1.8 B in 2024. Enterprise Value is likely to gain to about 1.7 B in 2024

Emergent Biosolutions Total Revenue

560.82 Million

Check Emergent Biosolutions financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Emergent Biosolutions' main balance sheet or income statement drivers, such as Depreciation And Amortization of 131.4 M, Interest Expense of 92.3 M or Total Revenue of 560.8 M, as well as many indicators such as Price To Sales Ratio of 0.11, Dividend Yield of 0.018 or PTB Ratio of 0.18. Emergent financial statements analysis is a perfect complement when working with Emergent Biosolutions Valuation or Volatility modules.
  
Check out the analysis of Emergent Biosolutions Correlation against competitors.
For more information on how to buy Emergent Stock please use our How to Invest in Emergent Biosolutions guide.

Emergent Biosolutions Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1.2 B1.8 B1.5 B
Slightly volatile
Short and Long Term Debt Total903.2 M860.2 M507.1 M
Slightly volatile
Other Current Liabilities66.5 M125.4 M81 M
Slightly volatile
Total Current Liabilities683.9 M651.3 M314.2 M
Slightly volatile
Property Plant And Equipment Net374.9 M399 M458.5 M
Slightly volatile
Accounts Payable61.7 M112.2 M74.4 M
Slightly volatile
Cash217 M111.7 M264.2 M
Slightly volatile
Non Current Assets Total799.2 M1.1 B1 B
Slightly volatile
Non Currrent Assets Other187 M178.1 M64.8 M
Slightly volatile
Cash And Short Term Investments217.2 M111.7 M264.3 M
Slightly volatile
Net Receivables136.2 M191 M166.7 M
Slightly volatile
Good Will142.3 M250.9 M140.7 M
Slightly volatile
Common Stock Shares Outstanding41.4 M51.2 M45 M
Slightly volatile
Liabilities And Stockholders Equity1.2 B1.8 B1.5 B
Slightly volatile
Non Current Liabilities Total394.8 M522.6 M512.8 M
Slightly volatile
Inventory345.3 M328.9 M188.2 M
Slightly volatile
Other Current Assets25.8 M47.9 M32 M
Slightly volatile
Total Liabilities1.2 B1.2 B745.4 M
Slightly volatile
Total Current Assets530.3 M679.5 M676.6 M
Slightly volatile
Short Term Debt434.4 M413.7 M140.6 M
Slightly volatile
Intangible Assets395 M566.6 M382 M
Slightly volatile
Common Stock61.4 K115 K70.3 K
Slightly volatile
Other Liabilities66.7 M104 M82 M
Slightly volatile
Current Deferred Revenue28.1 M30.4 M35.1 M
Slightly volatile
Long Term Debt290.2 M446.5 M358 M
Slightly volatile
Common Stock Total Equity120.8 K115 K68.8 K
Slightly volatile
Property Plant And Equipment Gross833.9 M794.2 M474.3 M
Slightly volatile
Property Plant Equipment987.3 M940.2 M494.2 M
Slightly volatile
Net Tangible Assets1 B1.6 B897.6 M
Slightly volatile
Long Term Debt Total520.5 M515.8 M382.2 M
Slightly volatile
Capital Surpluse663.5 M1 B543.9 M
Slightly volatile
Non Current Liabilities Other27.5 M28.9 M52.8 M
Slightly volatile
Short and Long Term Debt219 M413.7 M214.2 M
Pretty Stable
Deferred Long Term Asset Charges9 M10.2 M11.1 M
Slightly volatile
Cash And Equivalents403.8 M739 M356.1 M
Slightly volatile
Net Invested Capital2.2 B1.5 B1.5 B
Slightly volatile
Capital Stock80 K90 K98 K
Slightly volatile

Emergent Biosolutions Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization131.4 M125.1 M66.7 M
Slightly volatile
Total Revenue560.8 M1 B726.9 M
Slightly volatile
Other Operating Expenses1.8 B1.7 B850.9 M
Slightly volatile
Research Development128.2 M111.4 M155.9 M
Pretty Stable
Cost Of Revenue740.7 M705.4 M354.7 M
Slightly volatile
Total Operating Expenses1.1 B1 B496.2 M
Slightly volatile
Income Tax Expense24.3 M29.3 M29.6 M
Slightly volatile
Selling General Administrative391.5 M372.9 M204.6 M
Slightly volatile
Tax Provision48.4 M49.4 M44.4 M
Very volatile
Interest Income22 M42.9 M17 M
Slightly volatile
Reconciled Depreciation114.4 M131.2 M76 M
Slightly volatile

Emergent Biosolutions Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation19.2 M23.1 M21.8 M
Slightly volatile
Begin Period Cash Flow674.7 M642.6 M298.7 M
Slightly volatile
Depreciation131.4 M125.1 M66.7 M
Slightly volatile
Capital Expenditures67.9 M51.6 M75.6 M
Slightly volatile
End Period Cash Flow106.1 M111.7 M256.9 M
Slightly volatile
Change To Netincome44.4 M48.1 M38.5 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.110.11712.2969
Slightly volatile
Dividend Yield0.0180.02020.022
Slightly volatile
Days Sales Outstanding63.1266.4395201
Slightly volatile
Stock Based Compensation To Revenue0.02090.0220.0912
Slightly volatile
Capex To Depreciation0.390.41251.7812
Slightly volatile
EV To Sales0.790.83042.4976
Slightly volatile
Inventory Turnover2.412.14472.134
Pretty Stable
Days Of Inventory On Hand207170191
Pretty Stable
Payables Turnover6.66.2874.0271
Slightly volatile
Sales General And Administrative To Revenue0.310.30.2757
Very volatile
Research And Ddevelopement To Revenue0.10.10620.5065
Slightly volatile
Capex To Revenue0.04670.04920.4322
Slightly volatile
Cash Per Share3.792.18165.7965
Slightly volatile
Payout Ratio0.270.310.3352
Slightly volatile
Days Payables Outstanding55.1558.0564119
Slightly volatile
Income Quality0.260.27131.53
Slightly volatile
Intangibles To Total Assets0.30.31082.6598
Slightly volatile
Current Ratio0.991.04333.4197
Slightly volatile
Receivables Turnover7.165.49374.6663
Slightly volatile
Graham Number68.3665.101932.2536
Slightly volatile
Capex Per Share0.961.00782.3887
Slightly volatile
Revenue Per Share21.5220.494116.15
Slightly volatile
Interest Debt Per Share19.4418.517610.7118
Slightly volatile
Debt To Assets0.310.47180.3305
Pretty Stable
Operating Cycle385237400
Slightly volatile
Days Of Payables Outstanding55.1558.0564119
Slightly volatile
Dividend Payout Ratio0.270.310.3352
Slightly volatile
Ebt Per Ebit1.111.00661.0142
Pretty Stable
Long Term Debt To Capitalization0.430.40750.2814
Slightly volatile
Total Debt To Capitalization0.540.56991.7953
Slightly volatile
Quick Ratio0.510.53832.7412
Slightly volatile
Net Income Per E B T0.591.04010.755
Very volatile
Cash Ratio0.160.17151.5564
Slightly volatile
Days Of Inventory Outstanding207170191
Pretty Stable
Days Of Sales Outstanding63.1266.4395201
Slightly volatile
Fixed Asset Turnover1.972.62981.5741
Slightly volatile
Debt Ratio0.310.47180.3305
Pretty Stable
Price Sales Ratio0.110.11712.2969
Slightly volatile
Asset Turnover0.870.57550.6038
Slightly volatile

Emergent Biosolutions Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1.8 B1.7 B1.4 B
Slightly volatile
Enterprise Value1.7 B1.6 B1.3 B
Slightly volatile

Emergent Fundamental Market Drivers

Forward Price Earnings7.9428
Cash And Short Term Investments111.7 M

Emergent Upcoming Events

26th of February 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
26th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Emergent Biosolutions Financial Statements

Emergent Biosolutions shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Emergent Biosolutions investors may analyze each financial statement separately, they are all interrelated. The changes in Emergent Biosolutions' assets and liabilities, for example, are also reflected in the revenues and expenses on on Emergent Biosolutions' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue30.4 M28.1 M
Total Revenue1 B560.8 M
Cost Of Revenue705.4 M740.7 M
Stock Based Compensation To Revenue 0.02  0.02 
Sales General And Administrative To Revenue 0.30  0.31 
Research And Ddevelopement To Revenue 0.11  0.10 
Capex To Revenue 0.05  0.05 
Revenue Per Share 20.49  21.52 
Ebit Per Revenue(0.69)(0.66)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Emergent Stock Analysis

When running Emergent Biosolutions' price analysis, check to measure Emergent Biosolutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emergent Biosolutions is operating at the current time. Most of Emergent Biosolutions' value examination focuses on studying past and present price action to predict the probability of Emergent Biosolutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emergent Biosolutions' price. Additionally, you may evaluate how the addition of Emergent Biosolutions to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY